Home/Pipeline/BetaBart (RV‑01)

BetaBart (RV‑01)

B7H3‑positive solid tumors

Phase 1/2aActive

Key Facts

Indication

B7H3‑positive solid tumors

Phase

Phase 1/2a

Status

Active

Company

Radiopharm Theranostics

About Radiopharm Theranostics

RAD develops innovative radiopharmaceuticals to deliver precision oncology diagnostics and therapies.

View full company profile

Therapeutic Areas